Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05070338 · ClinicalTrials.gov registry record · NA
Postoperative Nudges to Reduce Opioid Prescribing
A NA study of Opioid Prescribing, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 640
- Enrollment target
- 1
- Study location
NCT05070338: Completed NA study of Opioid Prescribing, sponsored by RAND.
NCT05070338 is a NA study of Opioid Prescribing that has completed, run by RAND. The registered enrollment target is 640 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05070338, a NA study of Opioid Prescribing, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 640 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests the effectiveness of two email-based behavioral nudges, one based on peer behavior and one based on best practice guidelines, in reducing excessive opioid prescriptions after surgery. It will be conducted in three surgical specialties (general surgery, orthopedic surgery, and obstetric/gynecological surgery) at 19 hospitals within one healthcare system. These specialties will each be randomized to a control group or one of two nudge groups. Each month for one year, surgeons in the nudge groups will receive emails comparing their opioid prescribing either to their peers' prescribing or to prescribing guidelines. Both types of email-based nudges are expected to reduce opioid prescribing after surgery.
Primary Outcome
Prescriptions will be compared to prescribing guidelines via morphine milligram equivalents (MMEs) and coded as within or above guidelines. If no opioid is prescribed at discharge, this will be coded as within guidelines.
Conditions Studied
Interventions
- BEHAVIORAL Guideline-Based (Injunctive Norm) Nudges
- BEHAVIORAL Peer-Based (Social Norm) Nudges
Study Locations (1)
California
- Sutter Health - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2021-10-19 |
| Est. Completion | 2023-10-18 |
| Phase | NA |
What the finished NCT05070338 record still lists
NCT05070338 is an interventional study that assigns participants to a tested intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Opioid Prescribing appearing as the primary indexed condition, and to 2 interventions - of which Guideline-Based (Injunctive Norm) Nudges is the first listed.
NCT05070338 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05070338 about?
NCT05070338 is a clinical study titled "Postoperative Nudges to Reduce Opioid Prescribing". This study tests the effectiveness of two email-based behavioral nudges, one based on peer behavior and one based on best practice guidelines, in reducing excessive opioid prescriptions after surgery. It will be conducted in three surgical specialties (general surgery, orthopedic surgery, and obstet...
What is the current status of trial NCT05070338?
This trial is currently completed. It is a NA study. The enrollment target is 640 participants. The study started on 2021-10-19. Estimated completion is 2023-10-18.
What conditions does trial NCT05070338 study?
This clinical trial studies the following conditions: Opioid Prescribing.
What interventions are being tested in trial NCT05070338?
The interventions under investigation include: Guideline-Based (Injunctive Norm) Nudges (BEHAVIORAL), Peer-Based (Social Norm) Nudges (BEHAVIORAL).
Who is sponsoring clinical trial NCT05070338?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05070338 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Prescribing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05070338's enrollment target sits among peer trials
640 156th of 2000 higher than 1,844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI